BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boudinaud C, Abergel A, Joubert-Zakeyh J, Fontarensky M, Pereira B, Chauveau B, Garcier JM, Chabrot P, Boyer L, Magnin B. Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy. Eur J Radiol. 2019;118:169-174. [PMID: 31439237 DOI: 10.1016/j.ejrad.2019.07.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Choi Y, Kim DK, Youn SY, Kim H, Choi JI. Unenhanced computed tomography for non-invasive diagnosis of hepatic steatosis with low tube potential protocol. Quant Imaging Med Surg 2022;12:1348-58. [PMID: 35111629 DOI: 10.21037/qims-21-474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mertens J, Van Gaal LF, Francque SM, De Block C. NAFLD in type 1 diabetes: overrated or underappreciated? Ther Adv Endocrinol Metab 2021;12:20420188211055557. [PMID: 34840719 DOI: 10.1177/20420188211055557] [Reference Citation Analysis]
3 Hupfeld S, Pischel D, Jechorek D, Janicová A, Pech M, Fischbach F. MRI-based fat quantification of the liver: Is it time for commercially available products? Eur J Radiol 2021;144:109993. [PMID: 34656047 DOI: 10.1016/j.ejrad.2021.109993] [Reference Citation Analysis]
4 Ghadimi M, Habibabadi RR, Hazhirkarzar B, Shaghaghi M, Ameli S, Khoshpouri P, Ghasabeh MA, Gurakar A, Pawlik TM, Kamel IR. Advances in Imaging of Diffuse Parenchymal Liver Disease. J Clin Gastroenterol 2020;54:682-95. [PMID: 32554990 DOI: 10.1097/MCG.0000000000001380] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, Jun DW, Choi JI, Song DS, Kim W, Jeong SW, Kim MY, Koh H, Jeong S, Lee JW, Cho YK; Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2021;27:363-401. [PMID: 34154309 DOI: 10.3350/cmh.2021.0178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
6 Peng Y, Ye J, Liu C, Jia H, Sun J, Ling J, Prince M, Li C, Luo X. Simultaneous hepatic iron and fat quantification with dual-energy CT in a rabbit model of coexisting iron and fat. Quant Imaging Med Surg 2021;11:2001-12. [PMID: 33936981 DOI: 10.21037/qims-20-902] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Stahlschmidt FL, Tafarel JR, Menini-Stahlschmidt CM, Baena CP. Hepatorenal index for grading liver steatosis with concomitant fibrosis. PLoS One 2021;16:e0246837. [PMID: 33577616 DOI: 10.1371/journal.pone.0246837] [Reference Citation Analysis]
8 Ledda RE, Milanese G, Cademartiri F, Maffei E, Benedetti G, Goldoni M, Silva M, Sverzellati N. Association of hepatic steatosis with epicardial fat volume and coronary artery disease in symptomatic patients. Radiol Med 2021;126:652-60. [PMID: 33389661 DOI: 10.1007/s11547-020-01321-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Miele L, Zocco MA, Pizzolante F, De Matthaeis N, Ainora ME, Liguori A, Gasbarrini A, Grieco A, Rapaccini G. Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease. Metabolism 2020;112:154355. [DOI: 10.1016/j.metabol.2020.154355] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
10 Chen H, Zeng WK, Shi GZ, Gao M, Wang MZ, Shen J. Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis. World J Gastroenterol 2020; 26(33): 4996-5007 [PMID: 32952345 DOI: 10.3748/wjg.v26.i33.4996] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]